Highlights from the Turin international workshop on liver machine perfusion.
ex situ perfusion
liver
machine perfusion
meeting
organ preservation
transplantation
Journal
Artificial organs
ISSN: 1525-1594
Titre abrégé: Artif Organs
Pays: United States
ID NLM: 7802778
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
revised:
10
09
2022
received:
06
09
2022
accepted:
12
09
2022
pubmed:
24
9
2022
medline:
18
11
2022
entrez:
23
9
2022
Statut:
ppublish
Résumé
The 1st Turin international workshop on liver machine perfusion, which was held in Turin (Italy) on June 10th-11th, 2022, gathered more than 50 key opinion leaders and more than 220 delegates from 11 countries. The purpose of the meeting was discussing several aspects of liver machine perfusion in liver transplantation, including the state of the art, real-world clinical indications, and potential developments of this technology. We herein provide a brief summary of the evidence, perspectives and controversies presented during the meeting.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2511-2517Informations de copyright
© 2022 International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.
Références
Fodor M, Cardini B, Peter W, Weissenbacher A, Oberhuber R, Hautz T, et al. Static cold storage compared with normothermic machine perfusion of the liver and effect on ischaemic-type biliary lesions after transplantation: a propensity score-matched study. Br J Surg. 2021;108:1082-9.
Ravaioli M, Germinario G, Dajti G, Sessa M, Vasuri F, Siniscalchi A, et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-a randomized clinical trial. Am J Transplant. 2022.
Czigany Z, Pratschke J, Fronek J, Guba M, Schoning W, Raptis DA, et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD). Ann Surg. 2021;274:705-12.
Hessheimer AJ, de la Rosa G, Gastaca M, Ruiz P, Otero A, Gomez M, et al. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: outcomes and risk factors for graft loss. Am J Transplant. 2022;22:1169-81.
Guo Z, Xu J, Huang S, Yin M, Zhao Q, Ju W, et al. Abrogation of graft ischemia-reperfusion injury in ischemia-free liver transplantation. Clin Transl Med. 2022;12:e546.
Markmann JF, Abouljoud MS, Ghobrial RM, Bhati CS, Pelletier SJ, Lu AD, et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS liver PROTECT randomized clinical trial. JAMA Surg. 2022;157:189-98.
van Leeuwen OB, Bodewes SB, Lantinga VA, Haring MPD, Thorne AM, Bruggenwirth IMA, et al. Sequential hypothermic and normothermic machine perfusion enables safe transplantation of high-risk donor livers. Am J Transplant. 2022;22:1658-70.
Watson CJE, Gaurav R, Fear C, Swift L, Selves L, Ceresa CDL, et al. Predicting early allograft function after normothermic machine perfusion. Transplantation. 2022.
van Rijn R, Schurink IJ, de Vries Y, van den Berg AP, Cortes Cerisuelo M, Darwish Murad S, et al. Hypothermic machine perfusion in liver transplantation-a randomized trial. N Engl J Med. 2021;384:1391-401.
Hann A, Lembach H, Nutu A, Dassanayake B, Tillakaratne S, McKay SC, et al. Outcomes of normothermic machine perfusion of liver grafts in repeat liver transplantation (NAPLES initiative). Br J Surg. 2022;109:372-80.
Schlegel A, Muller X, Mueller M, Stepanova A, Kron P, de Rougemont O, et al. Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation. EBioMedicine. 2020;60:103014.
Kron P, Schlegel A, Mancina L, Clavien PA, Dutkowski P. Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans. J Hepatol. 2017;68:82-91.
Sampaziotis F, Muraro D, Tysoe OC, Sawiak S, Beach TE, Godfrey EM, et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science. 2021;371:839-46.